Long-term continuous external electrocardiographic recording: A review

Europace

Volumn 8, Issue 4, 2006, Pages 255-266

  Enseleit, Frank ^a   Duru, Firat ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Ambulatory electrocardiogram; Arrhythmia; Heart rate variability; Holter monitoring

Indexed keywords

ALGORITHM; AMBULATORY MONITORING; CARDIAC PATIENT; CONTINUOUS PROCESS; DATA ANALYSIS SOFTWARE; DATA STORAGE DEVICE; DRUG EFFICACY; ECG ABNORMALITY; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MEDICAL TECHNOLOGY; NON INVASIVE PROCEDURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECORDING; REVIEW; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; SOLID STATE; ST SEGMENT; TELEMETRY; THERAPY EFFECT;

ALGORITHMS; ARRHYTHMIA; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SOFTWARE;

EID: 33745189111     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euj054     Document Type: Review

References (131)

1. Holter NJ, Generelli JA. Remote recording of physiologic data by radio. Rocky Mountain Med J 1949;747-51.
2. Holter NJ. New method for heart studies. Science 1961;134:1214-20.
3. Heilbron EL. Advances in modern electrocardiographic equipment for long-term ambulatory monitoring. Card Electrophysiol Rev 2002;6:185-9.
4. Leitch J, Klein G, Yee R et al. Feasibility of an implantable arrhythmia monitor. Pacing Clin Electrophysiol 1992;15:2232-5.
5. Krahn AD, Klein GJ, Skanes AC et al. Use of the implantable loop recorder in evaluation of patients with unexplained syncope. J Cardiovasc Electrophysiol 2003;14(Suppl.):S70-S3.
6. Stein IM, Plunkett J, Troy M. Comparison of techniques for examining long-term ECG recordings. Med Instrum 1980;14:69-72.
7. Kuhn P, Kroiss A, Joskowicz G. Arrhythmia analysis-arrhythmia control: comparative studies of 4 small computers for automatic electrocardiography control. Z Kardiol 1976;65:166-75.
8. von Leitner ER, Tietze U, Andresen D et al. Computer compatible long-term ECG analysing system for quantitative detection of low grade and complex dysrhythmias: Methods and evaluation of the accuracy of analysis (author's transl). Z Kardiol 1981;70:22-7.
9. Pratt CM, Eaton T, Francis M et al. Ambulatory electrocardiographic recordings: The Holter monitor. Curr Probl Cardiol 1988;13:517-86.
10. Brandes A, Gonska BD, Distler WK et al. The reliability of computer-assisted long-term ECG analysis of pacemaker malfunction in patients with ventricular demand pacemakers. Z Kardiol 1994;83:351-8.
11. Stern S, Tzivoni D. Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J 1974;36:481-6.
12. Deanfield JE, Maseri A, Selwyn AP et al. Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet 1983;2:753-8.
13. Chierchia S, Lazzari M, Freedman B et al. Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol 1983;1:924-30.
14. Lanza GA, Mascellanti M, Placentino M et al. Usefulness of a third Holter lead for detection of myocardial ischemia. Am J Cardiol 1994;74:1216-9.
15. Stone PH, Chaitman BR, McMahon RP et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease. Circulation 1996;94:1537-44.
16. Kleiger RE, Stein PK, Bosner MS et al. Time domain measurements of heart rate variability. Cardiol Clin 1992;10:487-98.
17. Mullen TJ, Cohen RJ. RR interval monitoring. In Moss AJ, Stern S, eds. Nonivasive Electrocardiology: Clinical Aspects of Holter Monitoring. Vol. 1. London: W.B. Saunders Company Ltd; 1996. p155-62.
18. Hermes RE, Geselowitz DB, Olivier GC. Development, distribution, and use of the American Heart Association database for ventricular arrhythmia detector evaluation. Comput Cardiol 1981;263-6.
19. Taddei A, Distante G, Emdin M et al. The European ST-T database: standard for evaluating systems for the analysis of ST-T changes in ambulatory electrocardiography. Eur Heart J 1992;13:1164-72.
20. DiMarco JP, Philbrick JT. Use of ambulatory electrocardiographic (Holter) monitoring. Ann Intern Med 1990;113:53-68.
21. Bass EB, Curtiss EI, Arena VC et al. The duration of Holter monitoring in patients with syncope. Is 24 hours enough? Arch Intern Med 1990;150:1073-8.
22. Nabel EG, Barry J, Rocco MB et al. Variability of transient myocardial ischemia in ambulatory patients with coronary artery disease. Circulation 1988;78:60-7.
23. Tzivoni D, Gavish A, Benhorin J et al. Day-to-day variability of myocardial ischemic episodes in coronary artery disease. Am J Cardiol 1987;60:1003-5.
24. Crawford MH, Bernstein SJ, Deedwania PC et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999;34:912-48.
25. Zeldis SM, Hamby RI, Aintablian A. The clinical and hemodynamic significance of mitral regurgitation in coronary artery disease. Cathet Cardiovasc Diagn 1980;6:225-32.
26. Clark PI, Glasser SP, Spoto E Jr. Arrhythmias detected by ambulatory monitoring. Lack of correlation with symptoms of dizziness and syncope. Chest 1980;77:722-5.
27. Scalvini S, Zanelli E, Martinelli G et al. Cardiac event recorder yields more diagnoses than 24-hour Holter monitoring in patients with palpitations. Ital Heart J Suppl 2004;5:186-91.
28. Wu CC, Hsieh MH, Tai CT et al. Utility of patient-activated cardiac event recorders in the detection of cardiac arrhythmias. J Interv Card Electrophysiol 2003;8:117-20.
29. Balmelli N, Naegeli B, Bertel O. Diagnostic yield of automatic and patient-triggered ambulatory cardiac event recording in the evaluation of patients with palpitations, dizziness, or syncope. Clin Cardiol 2003;26:173-6.
30. Arjona Barrionuevo Jde D, Baron-Esquivias G, Nunez Rodriguez A et al. Utility of cardiac event recorders in diagnosing arrhythmic etiology of palpitations in patients without structural heart disease. Rev Esp Cardiol 2002;55:107-12.
31. Sovova E, Doupal V, Lukl J. Comparison of two types of devices for long-term Holter monitoring of the ECG in detection of heart arrhythmias. Vnitr Lek 2001;47:670-3.
32. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med 1999;130:848-56.
33. Kinlay S, Leitch JW, Neil A et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med 1996;124:16-20.
34. Zimetbaum PJ, Kim KY, Josephson ME et al. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. A cost-effectiveness analysis. Ann Intern Med 1998;128:890-5.
35. Kapoor WN, Karpf M, Wieand S et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204.
36. Soteriades ES, Evans JC, Larson MG et al. Incidence and prognosis of syncope. N Engl J Med 2002;347:878-85.
37. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore) 1990;69:160-75.
38. Linzer M, Pritchett EL, Pontinen M et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol 1990;66:214-9.
39. Wu J, Kessler DK, Chakko S et al. A cost-effectiveness strategy for transtelephonic arrhythmia monitoring. Am J Cardiol 1995;75:184-5.
40. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol 1997;79:207-8.
41. Zimetbaum P, Kim KY, Ho KK et al. Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol 1997;79:371-2.
42. Sivakumaran S, Krahn AD, Klein GJ et al. A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med 2003;115:1-5.
43. Krahn AD, Klein GJ, Yee R et al. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation 1999;99:406-10.
44. Ashby DT, Cehic DA, Disney PJ et al. A retrospective case study to assess the value of the implantable loop recorder for the investigation of undiagnosed syncope. Pacing Clin Electrophysiol 2002;25:1200-5.
45. Page RL, Wilkinson WE, Clair WK et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-7.
46. Yamanouchi H, Mizutani T, Matsushita S et al. Paroxysmal atrial fibrillation: High frequency of embolic brain infarction in elderly autopsy patients. Neurology 1997;49:1691-4.
47. Hornig CR, Haberbosch W, Lammers C et al. Specific cardiological evaluation after focal cerebral ischemia. Acta Neurol Scand 1996;93:297-302.
48. Richardt G, Ensle G, Schwarz F et al. Diagnosis of cardiac causes of cerebral embolism: Contribution by 2D echocardiography and long-term ECG. Z Kardiol 1989;78:598-601.
49. Koudstaal PJ, van Gijn J, Klootwijk AP et al. Holter monitoring in patients with transient and focal ischemic attacks of the brain. Stroke 1986;17:192-5.
50. Rem JA, Hachinski VC, Boughner DR et al. Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke 1985;16:950-6.
51. Come PC, Riley MF, Bivas NK. Roles of echocardiography and arrhythmia monitoring in the evaluation of patients with suspected systemic embolism. Ann Neurol 1983;13:527-31.
52. Abdon NJ, Zettervall O, Carlson J et al. Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long-term ECG in 86 patients. Stroke 1982;13:832-7.
53. Barthelemy JC, Feasson-Gerard S, Garnier P et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 2003;8:194-9.
54. Deedwania PC, Carbajal EV. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol 1990;65:1090-6.
55. Gottlieb SO, Weisfeldt ML, Ouyang P et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214-9.
56. Rocco MB, Nabel EG, Campbell S et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988;78:877-84.
57. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748-56.
58. Raby KE, Goldman L, Cook EF et al. Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. Am J Cardiol 1990;66:1309-13.
59. Tzivoni D, Gavish A, Zin D et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988;62:661-4.
60. Yeung AC, Barry J, Orav J et al. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease. Circulation 1991;83:1598-604.
61. Deedwania PC, Carbajal EV. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am J Cardiol 1991;68:1279-86.
62. de Marchena E, Asch J, Martinez J et al. Usefulness of persistent silent myocardial ischemia in predicting a high cardiac event rate in men with medically controlled, stable angina pectoris. Am J Cardiol 1994;73:390-2.
63. Madjlessi-Simon T, Mary-Krause M, Fillette F et al. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol 1996;27:1586-91.
64. Mulcahy D, Keegan J, Sparrow J et al. Ischemia in the ambulatory setting-the total ischemic burden: Relation to exercise testing and investigative and therapeutic implications. J Am Coll Cardiol 1989;14:1166-72.
65. Deedwania PC, Carbajal EV. Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris. Am J Cardiol 1990;66:1151-6.
66. Causse C, Allaert FA, Marcantoni JP et al. Frequency and detection rate of silent myocardial ischemia by Holter monitoring in patients with stable coronary insufficiency under treatment. Study of 95,725 recorded hours. Arch Mal Coeur Vaiss 2001;94:779-84.
67. Stone PH, Gibson RS, Glasser SP et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. Circulation 1990;82:1962-72.
68. Deedwania PC, Carbajal EV, Nelson JR et al. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol 1991;17:963-9.
69. Davies RF, Habibi H, Klinke WP et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. J Am Coll Cardiol 1995;25:619-25.
70. Pepine CJ, Cohn PF, Deedwania PC et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-8.
71. Knatterud GL, Bourassa MG, Pepine CJ et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol 1994;24:11-20.
72. Chaitman BR, Stone PH, Knatterud GL et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators. J Am Coll Cardiol 1995;26:585-93.
73. Bourassa MG, Pepine CJ, Forman SA, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators. J Am Coll Cardiol 1995;26:606-14.
74. Rogers WJ, Bourassa MG, Andrews TC, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators. J Am Coll Cardiol 1995;26:594-605.
75. Dargie HJ, Ford I, Fox KM. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J 1996;17:104-12.
76. Von Arnim T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis. Results of the Total Ischemic Burden Bisoprolol Study (TIBBs) follow-up. J Am Coll Cardiol 1996;28:20-24.
77. Huikuri HV, Mahaux V, Bloch-Thomsen PE. Cardiac arrhythmias and risk stratification after myocardial infarction: Results of the CARISMA pilot study. Pacing Clin Electrophysiol 2003;26:416-9.
78. Bigger JT, Jr., Fleiss JL, Kleiger R et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250-8.
79. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
80. McClements BM, Adgey AA. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993;21:1419-27.
81. Hohnloser SH, Franck P, Klingenheben T et al. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation 1994;90:1747-56.
82. Dittrich H, Gilpin E, Nicod P et al. Acute myocardial infarction in women: Influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7.
83. el-Sherif N, Denes P, Katz R et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. The Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/ SAECG) Substudy Investigators. J Am Coll Cardiol 1995;25:908-14.
84. Mukharji J, Rude RE, Poole WK et al. Risk factors for sudden death after acute myocardial infarction: Two-year follow-up. Am J Cardiol 1984;54:31-6.
85. Wolf MM, Varigos GA, Hunt D et al. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978;2:52-3.
86. Kleiger RE, Miller JP, Bigger JT Jr et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
87. Farrell TG, Bashir Y, Cripps T et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18:687-97.
88. Pedretti R, Etro MD, Laporta A et al. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993;71:1131-41.
89. La Rovere MT, Bigger JT, Marcus FI et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998;351:478-84.
90. Odemuyiwa O, Malik M, Farrell T et al. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. Am J Cardiol 1991;68:434-9.
91. Bigger JT Jr, Fleiss JL, Rolnitzky LM et al. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993;21:729-36.
92. Bilchick KC, Fetics B, Djoukeng R et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol 2002;90:24-8.
93. Nolan J, Batin PD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998;98:1510-16.
94. Fauchier L, Babuty D, Cosnay P et al. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999;33:1203-7.
95. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol 1996;28:1183-9.
96. Duru F, Candinas R, Dziekan G et al. Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction. Am Heart J 2000;140:157-61.
97. Schmidt G, Malik M, Barthel P et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999;353:1390-6.
98. Bauer A, Schmidt G. Heart rate turbulence. J Electrocardiol 2003;36(Suppl.):89-93.
99. Julian DG, Camm AJ, Frangin G et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-74.
100. Barthel P, Schneider R, Bauer A et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003;108:1221-6.
101. Watanabe MA, Schmidt G. Heart rate turbulence: A 5-year review. Heart Rhythm 2004;1:732-8.
102. Bonnemeier H, Wiegand UK, Friedlbinder J et al. Reflex cardiac activity in ischemia and reperfusion: Heart rate turbulence in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction. Circulation 2003;108:958-64.
103. Sade E, Aytemir K, Oto A et al. Assessment of heart rate turbulence in the acute phase of myocardial infarction for long-term prognosis. Pacing Clin Electrophysiol 2003;26:544-50.
104. Jokinen V, Tapanainen JM, Seppanen T et al. Temporal changes and prognostic significance of measures of heart rate dynamics after acute myocardial infarction in the beta-blocking era. Am J Cardiol 2003;92:907-12.
105. Singh SN, Fletcher RD, Fisher S et al. Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators. Am J Cardiol 1993;72:99F-102F.
106. Massie BM, Fisher SG, Radford M et al. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation 1996;93:2128-34.
107. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
108. Doval HC, Nul DR, Grancelli HO et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493-8.
109. Wilson JR, Schwartz JS, Sutton MS et al. Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2:403-10.
110. Huang SK, Messer JV, Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients. Am J Cardiol 1983;51:507-12.
111. Kron J, Hart M, Schual-Berke S et al. Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death. Chest 1988;93:85-90.
112. Grimm W, Glaveris C, Hoffmann J et al. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography. Am Heart J 2000;140:43-51.
113. Grimm W, Christ M, Bach J et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003;108:2883-91.
114. Singh SN, Fisher SG, Carson PE et al. Prevalence and significance of non-sustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol 1998;32:942-7.
115. Grimm W, Schmidt G, Maisch B et al. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 2003;14:819-24.
116. Malberg H, Bauernschmitt R, Meyerfeldt U et al. Short-term heart rate turbulence analysis versus variability and baroreceptor sensitivity in patients with dilated cardiomyopathy. Z Kardiol 2003;92:547-57.
117. Maron BJ, Savage DD, Wolfson JK et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981;48:252-7.
118. McKenna WJ, England D, Doi YL et al. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J 1981;46:168-72.
119. Fananapazir L, Chang AC, Epstein SE et al. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992;86:730-40.
120. Spirito P, Rapezzi C, Autore C et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation 1994;90:2743-7.
121. Cecchi F, Olivotto I, Montereggi A et al. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population. Heart 1998;79:331-6.
122. Monserrat L, Elliott PM, Gimeno JR et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003;42:873-9.
123. Kawasaki T, Azuma A, Asada S et al. Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J 2003;67:601-4.
124. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989;321:406-12.
125. Epstein AE, Bigger JT Jr, Wyse DG et al. Events in the Cardiac Arrhythmia Suppression Trial (CAST): Mortality in the entire population enrolled. J Am Coll Cardiol 1991;18:14-9.
126. Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
127. Rugg-Gunn FJ, Simister RJ, Squirrell M et al. Cardiac arrhythmias in focal epilepsy: A prospective long-term study. Lancet 2004;364:2212-9.
128. Shelbourne P, Winqvist R, Kunert E et al. Unstable DNA may be responsible for the incomplete penetrance of the myotonic dystrophy phenotype. Hum Mol Genet 1992;1:467-73.
129. Cannom DS, Wyman MG, Goldreyer BN. Clinical and induced ventricular tachycardia in a patient with myotonic dystrophy. J Am Coll Cardiol 1984;4:625-8.
130. Nguyen HH, Wolfe JT III, Holmes DR Jr et al. Pathology of the cardiac conduction system in myotonic dystrophy: A study of 12 cases. J Am Coll Cardiol 1988;11:662-71.
131. Hardin BA, Lowe MR, Bhakta D et al. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol 2003;8:227-32.